Anticancer prodrugs represent a promising strategy in modern medicine because they offer a way to improve therapeutic accuracy while limiting harmful side effects. Unlike conventional chemotherapy drugs that are active immediately after administration and can damage healthy cells, prodrugs are designed to remain inactive until they encounter specific biological triggers. Once activated at the desired location, they release their active therapeutic molecules and selectively target diseased tissues.
Read More